BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26694060)

  • 1. Thread sign in biliary intraductal papillary mucinous neoplasm: a novel specific finding for MRI.
    Hong GS; Byun JH; Kim JH; Kim HJ; Lee SS; Hong SM; Lee MG
    Eur Radiol; 2016 Sep; 26(9):3112-20. PubMed ID: 26694060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
    Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
    Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synchronous malignant intraductal papillary mucinous neoplasms of the bile duct and pancreas requiring left hepatectomy and total pancreatectomy].
    Moon DB; Lee SG; Jung DH; Park GC; Park YH; Park HW; Kim MH; Lee SK; Yu ES; Kim JH
    Korean J Gastroenterol; 2014 Feb; 63(2):129-33. PubMed ID: 24561701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of abbreviated MRI protocol in the surveillance of Branch-Duct intraductal papillary mucinous neoplasm.
    Malekzadeh S; Cannella R; Fournier I; Hiroz P; Mottet C; Constantin C; Widmer L
    Eur J Radiol; 2024 Jun; 175():111455. PubMed ID: 38608499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas.
    Jang KM; Kim SH; Min JH; Lee SJ; Kang TW; Lim S; Choi D
    AJR Am J Roentgenol; 2014 Nov; 203(5):992-1000. PubMed ID: 25341136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of intraductal papillary neoplasm of bile duct with respect to histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm.
    Nakanuma Y; Kakuda Y; Uesaka K; Miyata T; Yamamoto Y; Fukumura Y; Sato Y; Sasaki M; Harada K; Takase M
    Hum Pathol; 2016 May; 51():103-13. PubMed ID: 27067788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
    Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
    Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of intraductal papillary mucinous neoplasms of the pancreas on MDCT and MRI].
    Wang D; Zhou J; Zheng S; Xia J; Hu H
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):682-7. PubMed ID: 25564059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm.
    Ogawa T; Horaguchi J; Fujita N; Noda Y; Kobayashi G; Ito K; Koshita S; Kanno Y; Masu K; Sugita R
    J Hepatobiliary Pancreat Sci; 2014 Nov; 21(11):801-8. PubMed ID: 25082473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT and MR imaging features of fistulas from intraductal papillary mucinous neoplasms of the pancreas to adjacent organs: A retrospective study of 423 patients.
    Ravaud S; Laurent V; Jausset F; Cannard L; Mandry D; Oliver A; Claudon M
    Eur J Radiol; 2015 Nov; 84(11):2080-8. PubMed ID: 26321495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.
    Walter TC; Steffen IG; Stelter LH; Maurer MH; Bahra M; Faber W; Klein F; Bläker H; Hamm B; Denecke T; Grieser C
    Eur Radiol; 2015 May; 25(5):1329-38. PubMed ID: 25433414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts.
    Yeh TS; Tseng JH; Chiu CT; Liu NJ; Chen TC; Jan YY; Chen MF
    Ann Surg; 2006 Aug; 244(2):248-53. PubMed ID: 16858187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Imaging versus Computed Tomography for Biliary Tract Intraductal Papillary Mucinous Neoplasm (BT-IPMN): A Diagnostic Performance Analysis.
    Li J; Yu Y; Zhu L; Li Y; He Q
    Med Sci Monit; 2020 Apr; 26():e920952. PubMed ID: 32235820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.